TRAM Snapshot of App at Pub for Oppostn

CTX110

CRISPR Therapeutics AG

TRAM Snapshot of App at Pub for Oppostn

Trademark Snap Shot Publication Stylesheet
(Table presents the data on Publication Approval)

OVERVIEW

SERIAL NUMBER 88296694 FILING DATE 02/11/2019
REG NUMBER 0000000 REG DATE N/A
REGISTER PRINCIPAL MARK TYPE TRADEMARK
INTL REG # N/A INTL REG DATE N/A
TM ATTORNEY ONUOHA, UKACHUKWU FRED
L.O. ASSIGNED N30-NOT FOUND

PUB INFORMATION

RUN DATE 08/07/2019
PUB DATE N/A
STATUS 680-APPROVED FOR PUBLICATION
STATUS DATE 08/06/2019
LITERAL MARK ELEMENT CTX110

DATE ABANDONED N/A DATE CANCELLED N/A
SECTION 2F NO SECTION 2F IN PART NO
SECTION 8 NO SECTION 8 IN PART NO
SECTION 15 NO REPUB 12C N/A
RENEWAL FILED NO RENEWAL DATE N/A
DATE AMEND REG N/A


FILING BASIS

FILED BASIS CURRENT BASIS AMENDED BASIS
1 (a) NO 1 (a) NO 1 (a) NO
1 (b) YES 1 (b) YES 1 (b) NO
44D NO 44D NO 44D NO
44E NO 44E NO 44E NO
66A NO 66A NO

NO BASIS NO NO BASIS NO


MARK DATA

STANDARD CHARACTER MARK YES
LITERAL MARK ELEMENT CTX110
MARK DRAWING CODE 4-STANDARD CHARACTER MARK
COLOR DRAWING FLAG NO

CURRENT OWNER INFORMATION

PARTY TYPE 10-ORIGINAL APPLICANT
NAME CRISPR Therapeutics AG
ADDRESS Aeschenvorstadt 36
Basel, 4051
ENTITY 99-aktiengesellschaft
CITIZENSHIP Switzerland

GOODS AND SERVICES

INTERNATIONAL CLASS 005
          DESCRIPTION TEXT Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of cancer; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of cancer
INTERNATIONAL CLASS 042
          DESCRIPTION TEXT Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders; gene editing, namely, pharmaceutical research and development

GOODS AND SERVICES CLASSIFICATION

INTERNATIONAL CLASS 005 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE
INTERNATIONAL CLASS 042 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS

CHANGE IN REGISTRATION NO

PROSECUTION HISTORY

DATE ENT CD ENT TYPE DESCRIPTION ENT NUM
08/06/2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER 011
08/02/2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED 010
08/01/2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE 009
08/01/2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED 008
04/26/2019 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED 007
04/26/2019 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED 006
04/24/2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED 005
04/24/2019 GNRT F NON-FINAL ACTION E-MAILED 004
04/24/2019 CNRT R NON-FINAL ACTION WRITTEN 003
04/19/2019 DOCK D ASSIGNED TO EXAMINER 002
03/05/2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM 001

CURRENT CORRESPONDENCE INFORMATION

ATTORNEY Jess M. Collen
CORRESPONDENCE ADDRESS Jess M. Collen
COLLEN, Intellectual Property Law, P.C.
80 South Highland Avenue
Ossining NY 10562
DOMESTIC REPRESENTATIVE Jess M. Collen

TRAM Snapshot of App at Pub for Oppostn [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed